The pattern recognition module provides an execution environment for Short Line Candle recognition and related indicators on Pro Dex. Signals here center on pattern recognition signals tied to momentum and continuation alongside volatility and performance references.
The output start index for this execution was ten with a total number of output elements of fifty-one. The function generated a total of five valid pattern recognition events for the selected time horizon. The Short Line Candle pattern describes signals for either bullish or bearish trend during either reversal or continuation condition of Pro Dex.
Pro Dex Technical Analysis Modules
Most technical analysis of Pro Dex help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Pro from various momentum indicators to cycle indicators. When you analyze Pro charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company was founded in 1978 and is headquartered in Irvine, California. Pro Dex operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 134 people. The profile for Pro Dex integrates fundamentals, price behavior, and sector exposure. Cycle exposure remains aligned with broader market trends. Pro Dex has a market cap of 148.98 M, P/E of 13.3, ROE of 30.87%.
Methodology
Unless otherwise specified, financial data for Pro Dex is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Pro (USA Stocks:PDEX) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: We primarily rely on public filings and market reference sources, including disclosures published by U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Data is normalized for analytical consistency across reporting formats. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Pro Dex may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
Tracking Pro Dex inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.
Generate Optimal Portfolios
Align your risk and return expectations
By capturing risk tolerance and investment horizon, Macroaxis optimization evaluates acceptable risk for target return profiles. The process summarizes how much risk can be taken for a given return goal.
A structured review of Pro Dex often starts with core financial statements and trend context. Ratios and trend metrics help frame Pro Dex's operating context. Key reports that frame Pro Dex Stock are listed below:
Pro Dex has a market cap of 148.98 M, operating margin of 17.46%, ROE of 30.87%. Use Your Equity Center to explore allocation context. This includes a position in Pro Dex in the portfolio view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates.
To learn how to invest in Pro Stock, please use our How to Invest in Pro Dex guide.Analysis related to Pro Dex should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Quarterly Earnings Growth
0.082
Earnings Share
3.41
Revenue Per Share
22.127
Quarterly Revenue Growth
0.111
Return On Assets
0.1157
The market value of Pro Dex is measured differently than book value, which reflects Pro accounting equity. Pro Dex's market capitalization is 148.98 M. With a P/B ratio of 3.52, the market values Pro Dex well above its book equity. Enterprise value stands at 148.49 M. Intrinsic value is an analytical estimate of Pro Dex's underlying worth that can differ from price and book value. Valuation methods help interpret those gaps.
Note that Pro Dex's intrinsic value and market price are different measures derived from different inputs. For Pro Dex, key inputs include a P/E ratio of 13.3, a P/B ratio of 3.52, a profit margin of 15.73%, and ROE of 30.87%. Market price reflects the current exchange level formed by active bids and offers.
Rifka Kats ยท Member of Macroaxis Editorial Board